[1]
Dhone , P., Gulati, R., Sahu, P. and Mubeen, M.F. 2022. To evaluate the efficacy and safety profile of rosuvastatin, simvastatin and atorvastatin in newly diagnosed type 2 diabetic patients with dyslipidaemia. International journal of health sciences. 6, S6 (Jul. 2022), 1213–1221. DOI:https://doi.org/10.53730/ijhs.v6nS6.10585.